Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06460012 · ClinicalTrials.gov registry record · NA
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
A NA study of Caregiver Burden, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT06460012: Recruiting NA study of Caregiver Burden, sponsored by Oregon Health and Science University.
NCT06460012 is a NA study of Caregiver Burden that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 238 participants, roughly in line with the 239-participant average among 41 other Caregiver Burden trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06460012, a NA study of Caregiver Burden, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
STELLA-R is a multicomponent, self-directed, online intervention designed to facilitate effective management of behavioral and psychological symptoms that are common in many types of dementia. The curriculum instructs care partners to use the ABC approach, a cognitive behavioral technique that teaches care partners to describe a Behavior, then consider the Activators and Consequences of a care recipient behavior. The goal of this intervention is to reduce care partner burden and decrease reactivity to upsetting behaviors.
Primary Outcome
The primary outcome variable, reactivity, will be assessed with the RMBPC, which measures the frequency of care recipient behavioral symptoms and care partner reactions to these behaviors. The RMBPC was chosen because it aligns with our theoretical foundation that assumes burden is a result of care partner reactions to behavioral symptoms. The RMBPC is a 29-item caregiver report measure, 5-point Likert scale with frequency measuring from 0 (never occurred) to 4 (daily or more often) and reactiv
Conditions Studied
Interventions
- BEHAVIORAL STELLA-R Curriculum
- BEHAVIORAL Unrestricted Access
- BEHAVIORAL Limited Access
Study Locations (1)
Oregon
- Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06460012 shows while recruiting
NCT06460012 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 239-participant average among 41 other Caregiver Burden trials with a reported enrollment target.
The record links to 1 condition, with Caregiver Burden appearing as the primary indexed condition, and to 3 interventions - of which STELLA-R Curriculum is the first listed.
NCT06460012 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06460012 about?
NCT06460012 is a clinical study titled "Support Via Technology: Living and Learning With Advancing Dementia-REVISED". STELLA-R is a multicomponent, self-directed, online intervention designed to facilitate effective management of behavioral and psychological symptoms that are common in many types of dementia. The curriculum instructs care partners to use the ABC approach, a cognitive behavioral technique that teach...
What is the current status of trial NCT06460012?
This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2024-07-02. Estimated completion is 2026-12-01.
What conditions does trial NCT06460012 study?
This clinical trial studies the following conditions: Caregiver Burden.
What interventions are being tested in trial NCT06460012?
The interventions under investigation include: STELLA-R Curriculum (BEHAVIORAL), Unrestricted Access (BEHAVIORAL), Limited Access (BEHAVIORAL).
Who is sponsoring clinical trial NCT06460012?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06460012 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver Burden
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06460012's enrollment target sits among peer trials
238 12th of 41 higher than 30 of 41 other Caregiver Burden trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Telephone Support in Advanced Gastrointestinal Cancer
RECRUITING · NA
-
DECIDE: Dyads and Families
RECRUITING · NA
-
Learning Skills Together Family Caregiver Complex Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI